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What Is the Problem?
There are over 6 billion mobile phone
subscribers and 75% of the world has
access to a mobile phone [1]. Service and
care providers, researchers, and national
governments are excited at the opportu-
nities mobile health has to offer in terms of
improving access to health care, engage-
ment and delivery, and health outcomes
[2]. Interventions categorized under the
rubric ‘‘mobile health’’ or ‘‘mHealth’’—
broadly defined as medical and public
health practice supported by mobile de-
vices [2]—span a variety of applications
ranging from the use of mobile phones to
improve point of service data collection
[3], care delivery [4], and patient com-
munication [5] to the use of alternative
wireless devices for real-time medication
monitoring and adherence support [6].
A recent World Bank report tracked
more than 500 mHealth studies, and
many donor agencies are lining up to
support the ‘‘scaling up’’ of mHealth
interventions [7]. Yet, after completion of
these 500 pilot studies, we know almost
nothing about the likely uptake, best
strategies for engagement, efficacy, or
effectiveness of these initiatives. Currently,
mHealth interventions lack a foundation
of basic evidence [8], let alone a founda-
tion that would permit evidence-based
scale up. For example, in Uganda in
2008 and 2009 approximately 23 of 36
mHealth initiatives did not move beyond
the pilot phase [9]. The current enthusi-
asm notwithstanding, the scatter-shot ap-
proach to piloting mHealth projects in the
absence of a concomitant programmatic
implementation and evaluation strategy
may dampen opportunities to truly capi-
talize on the technology. This article
discusses a number of points pertinent to
developing a more robust evidence base
for the scale up of mHealth interventions.
The issues raised are primarily conceptual
and methodological.
Industry’s increasing role in pushing for
mHealth scale up is also a cause for
concern. At a recent mHealth conference
in South Africa, there were repeated calls
for scale up of mHealth initiatives across
low- and middle-income countries (LA-
MICs). Many of these calls emanated from
industry representatives rather than re-
searchers, governments, or care providers
[10]. It is likely that private enterprise has
a quite different understanding of what
scale up means, with growing market
share, rather than improved health out-
comes, at the core of their mission. The
growing involvement by industry, predom-
inantly mobile phone providers, warrants
some caution in addition to perhaps a
code of practice. Public–private partner-
ships will be of central importance in the
evolution of the mHealth field (as we
discuss later), but this cannot happen at
the expense of good science and good
public health.
In some ways, mobile technology has a
magical appeal for those interested in
global public health over and above the
advantages that have been proven with
good evidence [11]. Part of this magical
promise is that mobile technologies may
solve one of the most difficult problems
facing global health efforts—that of struc-
tural barriers to access. Travel, especially
to remote areas in LAMICs, is expensive,
destructive to the environment, time-
consuming, and exhausting and physically
challenging to many. In the global health
field, there are many practitioners whose
personal and working lives are substan-
tially disrupted by travel of this nature.
Mobile technology may hold out the
promise of a world within which these
difficulties can be minimised or eliminat-
ed. There is an obvious appeal for people
from higher-income contexts being able to
remain at home and in their offices while
interacting with and improving the health
of people very far away and in straitened
circumstances. Mobile technology may
hold out the promise that the visceral
challenges of travel and complex intercul-
tural contact, so much a feature of the
global health enterprise, may now be a
thing of the past [12].
Current State of the Evidence
While enthusiasm for effective mHealth
interventions in sub-Saharan Africa is
high, little is known about their efficacy
or effectiveness. Most randomized trials of
mHealth interventions have employed text
message reminder systems. Two systemat-
ic reviews have described a robust evi-
dence base for the use of text message
reminders to improve attendance at health
care appointments [13,14]. Yet, none of
the studies included in these reviews was
conducted in resource-limited settings.
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Similarly, few randomized trials evaluating
the use of text message reminders to
improve medication adherence for people
with chronic illnesses have been conducted
in LAMICs [15–18]. Three randomized
trials studying HIV treatment adherence
found benefits [19,20] and one found no
impact [21,22]. Two recent systematic
reviews [23,24] found modest and sugges-
tive evidence for the benefits of mHealth
technology, and while both reviews rec-
ommended implementation, they argued
that high quality (and adequately powered)
clinical trials that measure clinical out-
comes are essential.
The reviews of mHealth interventions
would be more helpful if the results were
organized according to 1) foundational
functions (informing, training, monitoring,
shaping, supporting, and linking to care);
2) content-specific targets (e.g., for Millen-
nium Development Goal developmentally
related tasks and challenges); and 3) local
cultural adaptations (e.g., language) [25].
The inconsistency of results from mHealth
studies demonstrates the importance of
having an organizational framework.
What Constitutes Evidence?
The Institute of Medicine [26] and
other communities of researchers [27,28]
have established standards for the phases
of research that must be conducted in
order to be considered efficacious, effec-
tive, and disseminated. Flay and col-
leagues [29] have adapted the evidentiary
standards model published by the Society
for Prevention Research [27]. These
standards were developed in order to
guide policy, research, and practice and
provide a useful framework to determine
what constitutes good and sufficient evi-
dence. In this model (see Figure 1), scale
up or country-wide implementation would
be dependent on the completion (for each
intervention) of (a) two high quality
efficacy trials, (b) two high quality effec-
tiveness trials, followed by (c) dissemina-
tion research that has established that the
intervention can be delivered with fidelity
to the model being tested, as well as (d)
information about the intervention’s costs.
There are currently no mHealth interven-
tions that meet these standards for scale up
despite numerous calls to scale up
mHealth projects.
Linked to the issue of standards for the
phases of research is the question of theories
of behaviour change. Aboud and Singla
[30] have shown how programmes that
simply provide health information (e.g., via
SMS [short message service, or text
messaging]) tend to be unsuccessful, while
interventions providing skills through peer
educators are more likely to be successful
[30]. There are well validated theories of
behaviour change common to many evi-
dence-based interventions for prevention,
diagnoses, and care, but none of the
mhealth initiatives appear to be grounded
in such theories [31]. We would argue that
in the context of scarce resources, imple-
menting untested mHealth interventions at
scale without a theory of behaviour change
is likely to result in many failed scale up
projects and significant levels of wasted
resources.
Finally, no major investments have been
made to create a robust platform for
mobile phones that could be used by
designers of applications and electronic
medical records that will allow cross-
fertilization or integrated systems to be
utilized [32]. Thousands of small applica-
tions have been propagated on closed-
source platforms (e.g., iPhone applications
and others) that each major mobile phone
provider appears ready to replicate at high
cost. Currently, a patient with two or more
health conditions will have to make use of
numerous applications for monitoring
different health-related parameters such
as medication adherence and health
status, a disease-specific approach that he
or she is unlikely to sustain [32]. Estrin
and Sim make the case that there is a
global communication network already in
place to support an open mHealth archi-
tecture that could facilitate scalable and
sustainable health information systems
[32]. Interoperability will be critical to
promote research initiatives. The largest
investments to date in interoperable sys-
tems have been actively pursued by for-
profit companies, given the staggering
profits to be made in the proprietary
applications market. What is needed is a
concerted effort by governments, funders,
and private enterprise to cooperate in
order to set standards (e.g., number of bits)
and to create a self-governing commer-
cially viable ecosystem for innovation [32].
mHealth is in a period very similar to the
early days of the Internet: not creating
robust, interoperable platforms will ensure
failure for mHealth initiatives to be scaled
to improve health outcomes for at least the
next decade.
What Needs to Happen Next:
From Black Box to High Utility
The current wave of mHealth interven-
tions are the equivalent of black boxes.
Each small entrepreneur or researcher
includes whatever bells and whistles that
their funding allows in an attempt to
demonstrate efficacy. For example, hun-
dreds of small pilot studies are finding
whether text messaging works. Text mes-
saging is more likely to work under a set of
parameters:
N when there is follow-up;
N when the message is personally tai-
lored;
N when the frequency, wording, and
content are highly relevant.
Similar strategies are being experiment-
ed with for a range of topics, delivery
strategies (web, phone, videos, social
media sties), and populations. There are
a set of principles that could potentially be
established to identify the optimal strate-
gies for delivering mHealth interventions.
However, our current research is not
aimed at identifying these principles and
strategies. Each pilot study is examining
whether their particular style of a black
box application works better than not
having any black box application. It is
time to start funding randomized con-
trolled trials of interventions that are based
on researchers’ best guesses about optimal
implementation.
It is also time to consider the Multi-
phase Optimization Strategy (MOST)
developed by Collins and colleagues [33].
The MOST strategy is grounded in an
engineering approach and requires a two-
stage process: 1) identifying the range of
features that contribute to variation for a
particular intervention; and 2) selecting a
small set of factors and empirically testing
them with a multi-factorial design. The
Summary Points
N Despite hundreds of mHealth pilot studies, there has been insufficient
programmatic evidence to inform implementation and scale-up of mHealth.
N We discuss what constitutes appropriate research evidence to inform scale up.
N Potential innovative research designs such as multi-factorial strategies,
randomized controlled trials, and data farming may provide this evidence base.
N We make a number of recommendations about evidence, interoperability, and
the role of governments, private enterprise, and researchers in relation to the
scale up of mHealth.
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initial set of factors to be screened might
be determined on the basis of theory and/
or experience and could be informed by
research implementing evidence-based in-
terventions with other delivery formats.
The utility of such an approach has been
demonstrated by Stretcher and colleagues
[34] for web-based smoking cessation
policies. Rather than having a single tested
web-based, evidence-based intervention
(EBI) that will then compete with other
web-based EBI for smoking, there are a set
of parameters that outline the optimal
strategy for implementing a web-based
programme. Similar strategies have long
been adopted by health services research-
ers [35]. However, few of the existing
studies utilizing mHealth delivery formats
have adopted such an approach.
MOST is not the only approach that
could potentially enhance the efficiency of
existing mHealth studies. Duan [35] has
advocated for the establishment of data
farms. Nascent Internet companies such as
Google, Yahoo, and Facebook provide
informative case studies of data farms.
Rather than use experimental research
designs (such as randomized controlled
trials), these companies can harvest data
from billions of users of mobile, web, and
social media, and computer-based inter-
ventions provide the evidence regarding
the specific types of consumers who are
attracted to specific types of delivery
formats delivered with specific levels of
doses at specific times. Data farms offer
the opportunity to know the who, what,
when, where, and how of reaching con-
sumers [36]. Private enterprise has been
outstanding at this function: mHealth
needs to utilize their platforms and
methods to optimize personal health.
Major donors could invest in creating a
robust set of standards and a platform that
can inform and support local adaptation of
mHealth applications. The standardized
features of the platform could then be
available to all local technicians commit-
ted to improving the health of their local
communities. At the very least, given that
standards are expensive to establish, as
Figure 1. Research stages and standards. Adapted from Olds et al. [29] and Flay et al. [27].
doi:10.1371/journal.pmed.1001382.g001
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well as often being complex and difficult to
understand, one option is for an organi-
zation such as the World Health Organi-
zation to ‘‘certify’’ standards that meet
particular criteria, or even to become a
disseminator of standards. We also believe
a global strategy for programmatic exam-
ination of the optimal features of the
mobile platforms is needed, namely a
platform that incorporates (for example)
factorial designs to test the multiple
features of interventions [37], the MOST
strategy and even data farms. This could
quickly identify and provide guidance to
hundreds of thousands of programmers
globally that could leverage donor invest-
ments to improve their communities’
access to information, skills, telemedicine,
or management of front line workers.
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